AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN - New York Stock Exchange, Inc. - US0017441017 - Common Stock - Currency: USD
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 102 industry peers in the Health Care Providers & Services industry. AMN has only an average score on both its financial health and profitability. AMN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
In the past year AMN had a positive cash flow from operations.
Of the past 5 years AMN 4 years were profitable.
In the past 5 years AMN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of AMN (-6.91%) is worse than 72.55% of its industry peers.
Looking at the Return On Equity, with a value of -23.13%, AMN is doing worse than 65.69% of the companies in the same industry.
The Return On Invested Capital of AMN (3.77%) is comparable to the rest of the industry.
AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.59%.
The last Return On Invested Capital (3.77%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.91% | ||
| ROE | -23.13% | ||
| ROIC | 3.77% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
With a Operating Margin value of 3.24%, AMN perfoms like the industry average, outperforming 53.92% of the companies in the same industry.
AMN's Operating Margin has declined in the last couple of years.
The Gross Margin of AMN (30.15%) is comparable to the rest of the industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.15% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), AMN is creating value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
Compared to 5 years ago, AMN has less shares outstanding
Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
AMN has an Altman-Z score of 2.38. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.38) which is in line with its industry peers.
The Debt to FCF ratio of AMN is 3.85, which is a good value as it means it would take AMN, 3.85 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.85, AMN is doing good in the industry, outperforming 72.55% of the companies in the same industry.
A Debt/Equity ratio of 1.39 is on the high side and indicates that AMN has dependencies on debt financing.
The Debt to Equity ratio of AMN (1.39) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | 3.85 | ||
| Altman-Z | 2.38 |
ROIC/WACC0.53
WACC7.12%
2.3 Liquidity
A Current Ratio of 1.08 indicates that AMN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.08, AMN is not doing good in the industry: 68.63% of the companies in the same industry are doing better.
A Quick Ratio of 1.08 indicates that AMN should not have too much problems paying its short term obligations.
AMN's Quick ratio of 1.08 is on the low side compared to the rest of the industry. AMN is outperformed by 63.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -57.98% in the last year.
Measured over the past 5 years, AMN shows a small growth in Earnings Per Share. The EPS has been growing by 0.80% on average per year.
The Revenue for AMN has decreased by -18.13% in the past year. This is quite bad
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-57.98%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-53.61%
Revenue 1Y (TTM)-18.13%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-16%
3.2 Future
The Earnings Per Share is expected to grow by 22.82% on average over the next years. This is a very strong growth
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-69.49%
EPS Next 2Y-32.83%
EPS Next 3Y-17.8%
EPS Next 5Y22.82%
Revenue Next Year-9.96%
Revenue Next 2Y-3.91%
Revenue Next 3Y-1%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.19 indicates a rather cheap valuation of AMN.
Based on the Price/Earnings ratio, AMN is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.43, AMN is valued rather cheaply.
The Price/Forward Earnings ratio is 13.42, which indicates a correct valuation of AMN.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than the industry average as 77.45% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, AMN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.19 | ||
| Fwd PE | 13.42 |
4.2 Price Multiples
86.27% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
99.02% of the companies in the same industry are more expensive than AMN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.96 | ||
| EV/EBITDA | 6.59 |
4.3 Compensation for Growth
A cheap valuation may be justified as AMN's earnings are expected to decrease with -17.80% in the coming years.
PEG (NY)N/A
PEG (5Y)8.93
EPS Next 2Y-32.83%
EPS Next 3Y-17.8%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
20.05
-0.39 (-1.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.48%
Inst Owner Change-0.1%
Ins Owners0.39%
Ins Owner Change4.65%
Market Cap767.51M
Analysts69.23
Price Target29.14 (45.34%)
Short Float %11.6%
Short Ratio4.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.13%
Min EPS beat(2)52.24%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)50.41%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)29.43%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)20.98%
Revenue beat(2)2
Avg Revenue beat(2)3.32%
Min Revenue beat(2)1.88%
Max Revenue beat(2)4.75%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.96%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.76%
Revenue beat(12)8
Avg Revenue beat(12)1.38%
Revenue beat(16)12
Avg Revenue beat(16)2.16%
PT rev (1m)0%
PT rev (3m)-22.78%
EPS NQ rev (1m)-17.45%
EPS NQ rev (3m)-28.45%
EPS NY rev (1m)3.36%
EPS NY rev (3m)-32.99%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)-1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.19 | ||
| Fwd PE | 13.42 | ||
| P/S | 0.27 | ||
| P/FCF | 2.96 | ||
| P/OCF | 2.31 | ||
| P/B | 1.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.59 |
EPS(TTM)2.79
EY13.92%
EPS(NY)1.49
Fwd EY7.45%
FCF(TTM)6.77
FCFY33.74%
OCF(TTM)8.67
OCFY43.22%
SpS74.52
BVpS18.68
TBVpS-14.22
PEG (NY)N/A
PEG (5Y)8.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.91% | ||
| ROE | -23.13% | ||
| ROCE | 5.09% | ||
| ROIC | 3.77% | ||
| ROICexc | 3.89% | ||
| ROICexgc | 13.75% | ||
| OM | 3.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.15% | ||
| FCFM | 9.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score3
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | 3.85 | ||
| Debt/EBITDA | 3.81 | ||
| Cap/Depr | 43% | ||
| Cap/Sales | 2.55% | ||
| Interest Coverage | 1.64 | ||
| Cash Conversion | 126.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.38 |
F-Score3
WACC7.12%
ROIC/WACC0.53
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.98%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-53.61%
EPS Next Y-69.49%
EPS Next 2Y-32.83%
EPS Next 3Y-17.8%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-18.13%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-16%
Revenue Next Year-9.96%
Revenue Next 2Y-3.91%
Revenue Next 3Y-1%
Revenue Next 5Y4.4%
EBIT growth 1Y-63.46%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year95.75%
EBIT Next 3Y30.53%
EBIT Next 5YN/A
FCF growth 1Y-37.16%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.25%
OCF growth 3Y1.61%
OCF growth 5Y7.34%